SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lynch Michael A

(Last)

(First)

(Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN

43017

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/31/2009

3. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO, Medical Segment

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	38,126	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)	⁽¹⁾	11/19/2011	Common Shares	14,945	$68.1	D
Option (right to buy)	⁽¹⁾	11/18/2012	Common Shares	17,598	$67.9	D
Option (right to buy)	⁽¹⁾	11/17/2013	Common Shares	18,699	$61.38	D
Option (right to buy)	⁽¹⁾	08/23/2014	Common Shares	32,463	$44.15	D
Option (right to buy)	⁽²⁾	09/02/2012	Common Shares	29,176	$58.88	D
Option (right to buy)	⁽³⁾	08/15/2013	Common Shares	26,590	$66.34	D
Option (right to buy)	⁽⁴⁾	08/15/2014	Common Shares	19,406	$67.26	D
Option (right to buy)	⁽⁵⁾	08/15/2015	Common Shares	32,004	$56.13	D
Option (right to buy)	⁽⁶⁾	07/20/2012	Common Shares	236	$31.27	D

Explanation of Responses:

1. These options are currently exercisable.

2. Three-quarters of these options are currently exercisable and one-quarter will vest on 9/2/2009.

3. Three-quarters of these options are currently exercisable and one-quarter will vest on 8/15/2010.

4. Two-thirds of these options are currently exercisable and one-third will vest on 8/15/2010.

5. One-third of these options are currently exercisable, one-third will vest on 8/15/2010, and one-third will vest on 8/15/2011.

6. These options will vest on 7/20/2010.

	/s/ Aneezal H. Mohamed, Attorney-in-fact	09/02/2009
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.